Methods and pharmaceutical compositions for the treatment of hepatitis B virus infection
US9895380B2 · kind B2 · utility
1Cited by
1References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 10, 2014 |
| Grant date | Feb 20, 2018 |
| Priority date | — |
| Expiry date | Nov 17, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods and pharmaceutical compositions for the treatment of hepatitis B virus infection. In particular, the present invention relates to farnesoid X receptor (FXR) agonists for use in a method for the treatment of hepatitis B virus infection in a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.